Reverse-phase phosphoproteome analysis of signaling pathways induced by rift valley fever virus in human small airway epithelial cells

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Popova, Taissia G ^a   Turell, Michael J ^b   Espina, Virginia ^a   Kehn Hall, Kylene ^a   Kidd, Jessica ^a   Narayanan, Aarthi ^a   Liotta, Lance ^a   Petricoin III, Emanuel F ^a   Kashanchi, Fatah ^a   Bailey, Charles ^a   Popov, Serguei G ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b US Army Medical Research Institute of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; PROTEIN KINASE B; PROTEIN P53; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOME; TRANSCRIPTION FACTOR; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CASE REPORT; CELL CYCLE ARREST; CHILD; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; RESPIRATORY EPITHELIUM; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SCHOOL CHILD; SIGNAL TRANSDUCTION; TISSUE CULTURE; TRANSCRIPTION INITIATION; VIRUS STRAIN; CELL CULTURE; CYTOLOGY; HOST PATHOGEN INTERACTION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; VIROLOGY; WESTERN BLOTTING;

RIFT VALLEY FEVER VIRUS;

BLOTTING, WESTERN; CASPASES; CELLS, CULTURED; CHILD; EPITHELIAL CELLS; FEMALE; HOST-PATHOGEN INTERACTIONS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PROTEOME; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY SYSTEM; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 78149481208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013805     Document Type: Article

References (44)

1. Balkhy HH, Memish ZA (2003) Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents 21: 153-157.
2. Peters CJ, Meegan JM (1989) Rift Valley fever. CRC Press: Boca Raton, FL.
3. Gerdes GH (2002) Rift valley fever. Vet Clin N Am Food Anim Pract 18: 549-555.
4. Flick R, Bouloy M (2005) Rift Valley virus. Curr Mol Med 5: 827-834.
5. Brown JL, Dominik JW, Morrissey RL (1981) Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun 33: 848-853.
6. Easterday BC (1965) Rift Valley fever. Adv Vet Sci 10: 65-127.
7. Elliott RM, Bouloy M, Calisher CH, Goldbach R, Moyer JT, et al. (2000) Family Bunyaviridae, p. 614-616. In Van Regenmortel MHV, Fauquet C, Bishop DHL, Cartens EB, Estes MK, et al. (ed.), Virus taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses. Academic Press, Inc.: San Diego, CA.
8. Won S, Ikegami T, Peters CJ, Makino S (2007) NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol 81: 13335-13345.
9. Ikegami T, Won S, Peters CJ, Makino S (2006) Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80: 2933-2940.
10. Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, et al. (2001) Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75: 1371-1377.
11. Le May N, Mansuroglu Z, Leger P, Josse T, Blot G, et al. (2008) A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4: e13.
12. Ikegami T, Narayanan K, Won S, Kamitani W, Peter CJ, et al. (2009) Rift Valley fever virus NSs protein promotes posttranscriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5: e1000287.
13. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, et al. (2004) TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116: 541-550.
14. Ludwig S (2009) Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrob Chemoth 64: 1-4.
15. Meegan JM (1979) The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 73: 618-623.
16. Wulfkuhle JD, Edmiston KH, Liotta LA, Petricoin EF, III (2006) Technology insight: pharmacoproteomics for cancer -promises of patient-tailored medicine using protein microarrays. Nat Clin Pract Oncol 3: 256-268.
17. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, et al. (1999) HSP 27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13: 2061-2070.
18. Davis R (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
19. Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
20. Li S-P, Junttila MR, Han J, Kähäri V-M, Westermarck J (2003) p38 Mitogenactivated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase 1,2. Cancer Res 63: 3473-3477.
21. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, et al. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228.
22. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, et al. (2004) P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15: 922-933.
23. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
24. Bulavin DV, Fornace AJ Jr (2004) p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 92: 95-118.
25. Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, et al. (2005) p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res 65: 1792-1799.
26. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183.
27. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: Downstream AKTion Blocks Apoptosis Cell 88: 435-437.
28. Burgering BM, Coffer PJ (1995) Proteine kinase B (c-AKT) in phosphatidylinositol-3-OH kinase signaling transduction. Nature 376: 599-602.
29. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, et al. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGFactivated phosphatidylinositol 3-kinase. Cell 81: 727-736.
30. Altieri DC, Marchisio PC (1999) Surviving apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327-1333.
31. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-803.
32. Kasof GM, Gomes BC (2001) Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276: 3238-46.
33. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell death proteases. Nature 388: 300-304.
34. Ji WT, Liu HJ (2008) PI3K-Akt signaling and viral infection. Recent Pat Biotechnol 2: 218-26.
35. Eckelmam, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988-994.
36. Cain K, Bratton SB, Cohen GM (2002) The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84: 203-214.
37. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, et al. (2000) Alpha/beta interferons potentiate virus-induced apoptosis through activation of FADD/Caspase-8 death signaling pathway. J Virol 74: 1513-1523.
38. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, et al. (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22: 2717-28.
39. Sandhu KS, Al-Rubeai M (2009) The effect of Bcl-2, YAMA, and XIAP overexpression on apoptosis and adenovirus production in HEK293 cell line. Biotechnol Bioeng 104: 752-765.
40. Olsson A, Manzl C, Strasser A, Villunger A (2007) How important are posttranslational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death and Differentiation 14: 1561-1575.
41. Ballif BA, Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12: 397-408.
42. Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31: 151-174.
43. Meloche S, Pouyssegur J (2007) The ERK1/2 mitogenactivated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239.
44. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, et al. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signaling cascade. Nat Cell Biol 3: 301-305.